# Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days

> **NCT01203046** · PHASE2,PHASE3 · COMPLETED · sponsor: **Silvia M. Pinango L.** · enrollment: 56 (actual)

## Conditions studied

- SURGICAL SITE INFECTION

## Interventions

- **DRUG:** Ertapenem

## Key facts

- **NCT ID:** NCT01203046
- **Lead sponsor:** Silvia M. Pinango L.
- **Sponsor class:** INDIV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2012-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203046, "Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01203046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*